ARDT INVESTIGATION ALERT: Investigation Launched into Ardent Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - ARDT

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.

If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and would like to learn more, you can provide your information here:

https://www.rgrdlaw.com/cases-ardent-health-inc-investigation-ardt.html

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

THE COMPANY: Ardent Health is a provider of healthcare in growing midsize urban communities across the United States. On July 18, 2024, Ardent Health raised $192 million in its initial public offering, selling 12 million shares of its common stock for $16 per share.

THE REVELATION: On November 12, 2025, Ardent Health announced its third quarter 2025 earnings, revealing that it had missed consensus estimates due in large part "payor denials [that] were more pronounced" and "an adjustment of $54 million attributable to the emergence of adverse prior period claim developments with respect to recent settlements and ongoing litigation arising from a limited set of claims between 2019 and 2022 in New Mexico for a single provider who the Company no longer employs, as well as consideration of broader industry trends, including social inflationary pressures." Regarding the payor shortfall, CFO Alfred Lumsdaine further announced that Ardent Health had implemented a "change in accounting estimate" that required Ardent Health to "recognize[] reserves earlier in an account's life cycle." As a result, Ardent Health reduced revenue in the quarter by $43 million.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices. 

Contact:

Robbins Geller Rudman & Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
[email protected] 

SOURCE Robbins Geller Rudman & Dowd LLP